Survey of Susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Isolates to 26 Antimicrobial Agents: a Prospective U.S. Study

Documenti analoghi

• Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
  di: Critchley, Ian A., et al.
  Pubblicazione: (2002)
• Multicenter Surveillance of Antimicrobial Resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998–1999 Respiratory Season
  di: Hsueh, Po-Ren, et al.
  Pubblicazione: (2000)
• Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States
  di: Karlowsky, James A., et al.
  Pubblicazione: (2003)
• Connection between Trimethoprim-Sulfamethoxazole Use and Resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
  di: Kärpänoja, Pauliina, et al.
  Pubblicazione: (2008)
• In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
  di: Flamm, Robert K., et al.
  Pubblicazione: (2016)